Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
37.67 USD -0.21% Intraday chart for Celldex Therapeutics, Inc. -4.56% -5.02%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI
6a722a.xUifxT-_Obj0MFIWog770t81pH6RlKBLfzaaQkAlG8k.pCPMnHjxV86lVDpa5EfJvLds7TKo15QhHX3rd3ZxaYGWBvKhD8tu_KRoag~93700bfa06dcfc80d847415d09b47474
  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. Charts Celldex Therapeutics, Inc.
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW